193
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Avelumab for Advanced Merkel Cell Carcinoma: Global Real-World Data on Patient Response and Survival

, , , ORCID Icon & ORCID Icon
Pages 149-154 | Received 31 Jul 2023, Accepted 10 Nov 2023, Published online: 15 Nov 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.